Learn how to price better than your competitors for successful market access with CEL for Pharma, 30th September – 1st October 2025, Brussels.
The mix of stakeholders (who influence the impact of access hurdles) changes with the country and the setting of care – which makes developing a pricing strategy that optimizes market access difficult. Understanding value pricing in pharma’s multi-stakeholder and international environment is therefore critical for pricing executives, and for all functions interacting with key stakeholders in the market access process.
Discover the techniques and approaches that have been proven to work best for value pricing in pharma from our chairman, Gary Johnson, and director of research and development, Sam Johnson, through this course facilitated by CEL for Pharma.
Register for CEL for Pharma’s course here.
By clicking this link, you will be leaving our website. Inpharmation is not responsible for the content of the destination site. You will be subject to the destination site’s privacy policy and terms and conditions when you follow the link.